Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study

Overview of attention for article published in Cancer (0008543X), December 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter: 26 X users

Readers on

mendeley: 49 Mendeley

So far, Altmetric has seen 29 X posts from 26 X users, with an upper bound of 150,991 followers.

@MikeLattanzi @OAlhalabiMD @MDAndersonNews @ASCO @PGrivasMDPhD @rafee_talukder @VivekSubbiah UNITE #RWE study showed ORR 57% among 28 patients with FGFR alteration with EV alone. https://t.co/sWLtcbBZFg @koshkin85 @AlvaAjjai @deepak_kilari

RT @arkhaki: @PTsantoulis @DRBakaloudiMD @RishiSekarMD @LDiamantMD @spsutkaMD @HsiehLab @PGrivasMDPhD @JLWrightMD In #UNITE study, 2/4 pati…

@PTsantoulis @DRBakaloudiMD @RishiSekarMD @LDiamantMD @spsutkaMD @HsiehLab @PGrivasMDPhD @JLWrightMD In #UNITE study, 2/4 patients treated with EV had PR https://t.co/sWLtcbCxuO @koshkin85 @AlvaAjjai @deepak_kilari

RT @koshkin85: Our initial pub from multi-institutional UNITE study @JournalCancer focusing on #enfortumab efficacy in #BladderCancer subse…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 25 additional X posts.